CGP 57813

• Description :

  CGP 57813 is a peptidomimetic inhibitor of HIV protease that can be encapsulated by nanoparticles composed of poly (D, L-lactic acid) (PLA) and pH-sensitive methacrylic acid copolymers and delivered into the body[1].

• UNSPSC :

  12352005

• Target :

  HIV; HIV Protease

• Type :

  Reference compound

• Related Pathways :

  Anti-infection; Metabolic Enzyme/Protease

• Field of Research :

  Infection

• Assay Protocol :

  https://www.medchemexpress.com/cgp-57813.html

• Smiles :

  O=C(N1CCOCC1)[C@H](CC2=CC=CC=C2)NC([C@H](C(C)C)NC([C@H](CC3=CC=C(OC)C=C3)C[C@H](O)[C@@H](NC(OC(C)(C)C)=O)CC4=CC=CC=C4)=O)=O

• Molecular Formula :

  C43H58N4O8

• Molecular Weight :

  758.94

• References & Citations :

  [1]Leroux JC, et al. Pharmacokinetics of a novel HIV-1 protease inhibitor incorporated into biodegradable or enteric nanoparticles following intravenous and oral administration to mice. J Pharm Sci. 1995 Dec;84 (12) :1387-91.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [150608-41-6]